Invezz
16 Oct 2026, 17:35 UTC · 1h ago
Why is Moderna down 10% on Friday?
Impact · against what's priced in
The current price of Moderna is under pressure as it is trading significantly above analyst valuation targets, highlighting a disconnect between market optimism and fundamental models. While Merck is positioned as a lower-risk way to play the same oncology theme, the lack of new clinical data means the overarching catalyst for the partnership remains unchanged.
- MRNA−0.50
Challenges what's priced in
- The price assumes
A platform premium that assigns an enterprise value of $53.8 billion
The market is struggling to justify the current $212 price, as Goldman Sachs' raised price target of $137 still represents a significant discount, reinforcing the risk that the platform premium is overextended.
What MRNA's price assumes · Sep 11
